Phase 2a, Open-Label, 4-Escalating-Dose, Randomized Multicenter Study Evaluating the Safety and Activity of Ferroquine (SSR97193) Plus Artesunate, versus Amodiaquine Plus Artesunate, in African Adult Men with Uncomplicated Plasmodium falciparum Malaria

DSpace Repository

Phase 2a, Open-Label, 4-Escalating-Dose, Randomized Multicenter Study Evaluating the Safety and Activity of Ferroquine (SSR97193) Plus Artesunate, versus Amodiaquine Plus Artesunate, in African Adult Men with Uncomplicated Plasmodium falciparum Malaria

Author: Supan, Christian; Mombo-Ngoma, Ghyslain; Kombila, Maryvonne; Salazar, Carmen L. Ospina; Held, Jana; Lell, Bertrand; Cantalloube, Cathy; Djeriou, Elhadj; Ogutu, Bernhards; Waitumbi, John; Otsula, Nekoye; Apollo, Duncan; Polhemus, Mark E.; Kremsner, Peter G.; Walsh, Douglas S.
Tübinger Autor(en):
Supan, Christian
Mombo-Ngoma, Ghyslain
Held, Jana
Lell, Bertrand
Kremsner, Peter
Salazar, Carmen Lucelly Ospina
Published in: American Journal of Tropical Medicine and Hygiene (2017), Bd. 97, H. 2, S. 514-525
Verlagsangabe: Amer Soc Trop Med & Hygiene
Language: English
Full text: http://dx.doi.org/10.4269/ajtmh.16-0731
ISSN: 1476-1645
DDC Classifikation: 300 - Social sciences, sociology and anthropology
610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)